Evidence map›Paper›PMID 21147852›Full record

ArticleJournal of cell science2011

Targeted JAM-C deletion in germ cells by Spo11-controlled Cre recombinase.

Manuela Pellegrini, Giuseppina Claps, Valeria V Orlova, Florencia Barrios, Susanna Dolci, Raffaele Geremia, Pellegrino Rossi, Gabriele Rossi, Bernd Arnold, Triantafyllos Chavakis and 3 more

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Journal of cell science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. The Roles of Junctional Adhesion Molecules (JAMs) in Cell Migration.Frontiers in cell and developmental biology · 2022
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neutrophil-Epithelial Interactions: A Double-Edged Sword.The American journal of pathology · 2016
    Review
  11. Article
  12. Manipulating the Mouse Genome Using Recombineering.Advancements in genetic engineering · 2013
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Manuela PellegriniDepartment of Public Health and Cellular Biology, University of Rome 'Tor Vergata', 00133 Rome, Italy. manuelapellegrini@libero.it
Giuseppina Claps
Valeria V Orlova
Florencia Barrios
Susanna Dolci
Raffaele Geremia
Pellegrino Rossi
Gabriele Rossi
Bernd Arnold
Triantafyllos Chavakis
Lionel Feigenbaum
Shyam K Sharan
Andre Nussenzweig
University of Rome Tor Vergata · ITCancer Genetics (United States) · USGerman Cancer Research Center · DELeiden University Medical Center · NLNational Cancer Institute · USScience Applications International Corporation (United States) · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Meiosis is a crucial process for the production of functional gametes. However, the biological significance of many genes expressed during the meiotic phase remains poorly understood, mainly because of the lethal phenotypes of the knockout mice. Functional analysis of such genes using the conditional knockout approach is hindered by the lack of suitable Cre transgenic lines. We describe here the generation of transgenic mice expressing Cre recombinase under the control of the meiotic Spo11 gene. Using LacZ-R26(loxP) and EYFP-R26(loxP) reporter mice, we show the specific expression and activity of Cre during meiosis in males and females. Spo11(Cre) mice were then crossed with floxed Nbs1 and JAM-C mice to produce conditional knockouts. A strong reduction of Nbs1 and JAM-C protein levels was found in the testis. Although Nbs1-deleted mice developed minor gonadal abnormalities, JAM-C-knockout mice showed a spermiogenetic arrest, as previously described for the null mice. These results provide strong evidence that Spo11(Cre) transgenic mice represent a powerful tool for deleting genes of interest specifically in meiotic and/or in postmeiotic germ cells.

Indexed as

Gene DeletionAnimalsEndodeoxyribonucleasesFemaleGene TargetingGerm CellsIntegrasesMaleMeiotic Recombination Protein SPO11MiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMiosisPromoter Regions, GeneticCre recombinaseEndodeoxyribonucleasesIntegrasesMeiotic Recombination Protein SPO11

Identifiers

PMID21147852
PMCPMC3001409
OpenAlexW2122188779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.